Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Norortho AS
AS
Active
Org 984588267
C. J. Hambros Plass 2C, 0164
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2002 · 24 years old
5 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Norortho AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
64M
48M
32M
16M
0M
2020: 25M
25M
2020
2021: 35M (+40% vs 2020)
35M
+40%
2021
2022: 40M (+14% vs 2021)
40M
+14%
2022
2023: 49M (+23% vs 2022)
49M
+23%
2023
2024: 51M (+4% vs 2023)
51M
+4%
2024
EBITDA
NOK millions
4M
3M
2M
1M
0M
2020: 2M
2M
2020
2021: 1M (-50% vs 2020)
1M
-50%
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 3M (+200% vs 2022)
3M
+200%
2023
2024: 2M (-33% vs 2023)
2M
-33%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
51 172
49 225
39 744
35 231
25 274
Staff expenses
−9 283
−8 111
−6 215
−4 940
−3 395
EBITDA
2 308
3 377
948
1 107
2 016
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
2 308
3 377
948
1 107
2 016
Net financials
6
−1 436
−200
−332
−1 393
Profit before tax
2 313
1 940
748
775
623
Tax
601
498
215
188
141
Net profit
1 713
1 443
533
587
483
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
31 591
22 446
22 090
15 570
11 929
Equity
10 564
8 851
7 409
6 876
6 289
Long-term debt
0
0
0
0
0
Short-term debt
21 027
13 594
14 682
8 695
5 640
Total debt
21 027
13 594
14 682
8 695
5 640
Financial ratios
5-year trend
EBITDA margin
4,5 %
This company
15,8 %
Market median
This company
Market median
72% below market
2020
2024
Equity ratio
33,4 %
This company
38,2 %
Market median
This company
Market median
13% below market
2020
2024
Return on equity
16,2 %
This company
18,4 %
Market median
This company
Market median
12% below market
2020
2024
Net profit margin
3,3 %
This company
8,1 %
Market median
This company
Market median
59% below market
2020
2024
Asset turnover
1,62×
This company
1,12×
Market median
This company
Market median
45% above market
2020
2024
Debt / equity
1,99×
This company
0,62×
Market median
This company
Market median
221% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Norortho AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
